Cure My Disease

Don't miss your cure!

 Log in / Sign up

New biobank aims to unlock why kidney disease returns after transplant

NCT ID NCT05650619

Recruiting now Knowledge-focused Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is collecting medical information and biological samples (like blood, urine, and kidney tissue) from 300 people with FSGS or MCD who have had or will have a kidney transplant. The goal is to build a research biobank called RESOLVE to help scientists study why these diseases sometimes come back after transplant. No new treatments are being tested—this is purely an effort to gather data for future research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help researchers better understand why FSGS and MCD sometimes return after a kidney transplant, potentially pointing toward new treatments.
What could go wrong
This is an observational study, not a treatment trial. It will not directly test any new drug or therapy, and results may take years to influence patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOCAL SEGMENTAL GLOMERULOSCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

focal segmental glomerulosclerosis kidney disorder lipoid nephrosis macular corneal dystrophy Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FOCAL SEGMENTAL GLOMERULOSCLEROSIS FSGS MCD MINIMAL CHANGE DISEASE

Contacts and locations

Locations

  • University of Michigan

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.